ID: ALA2089168

Max Phase: Preclinical

Molecular Formula: C26H33N5O5

Molecular Weight: 495.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)C[C@H](NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)NO

Standard InChI:  InChI=1S/C26H33N5O5/c1-15(2)11-22(25(34)30-23(26(35)31-36)12-16-7-9-18(32)10-8-16)29-24(33)20(27)13-17-14-28-21-6-4-3-5-19(17)21/h3-10,14-15,20,22-23,28,32,36H,11-13,27H2,1-2H3,(H,29,33)(H,30,34)(H,31,35)/t20-,22-,23-/m0/s1

Standard InChI Key:  DZWQLLAUWXWUFB-PMVMPFDFSA-N

Associated Targets(non-human)

Snake venom metalloproteinase Bap1 31 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 495.58Molecular Weight (Monoisotopic): 495.2482AlogP: 1.51#Rotatable Bonds: 11
Polar Surface Area: 169.57Molecular Species: BASEHBA: 6HBD: 7
#RO5 Violations: 1HBA (Lipinski): 10HBD (Lipinski): 8#RO5 Violations (Lipinski): 1
CX Acidic pKa: 8.65CX Basic pKa: 9.58CX LogP: 1.65CX LogD: 1.43
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.16Np Likeness Score: 0.23

References

1. Villalta-Romero F, Gortat A, Herrera AE, Arguedas R, Quesada J, de Melo RL, Calvete JJ, Montero M, Murillo R, Rucavado A, Gutiérrez JM, Pérez-Payá E..  (2012)  Identification of new snake venom metalloproteinase inhibitors using compound screening and rational Peptide design.,  (7): [PMID:24900507] [10.1021/ml300068r]

Source